ASP Isotopes (NASDAQ:ASPI) Trading 8.4% Higher – What’s Next?

ASP Isotopes Inc. (NASDAQ:ASPI)’s share price was up 8.4% on Thursday . The stock traded as high as $7.59 and last traded at $7.6870. Approximately 1,708,891 shares changed hands during trading, a decline of 71% from the average daily volume of 5,853,471 shares. The stock had previously closed at $7.09.

Analysts Set New Price Targets

Several brokerages recently issued reports on ASPI. Canaccord Genuity Group reissued a “buy” rating and issued a $11.00 price objective on shares of ASP Isotopes in a research note on Monday, November 24th. Cantor Fitzgerald started coverage on ASP Isotopes in a research note on Thursday, December 4th. They set an “overweight” rating and a $13.00 price target on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Monday, December 29th. Finally, Loop Capital set a $15.00 price target on shares of ASP Isotopes in a report on Monday, October 27th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $13.00.

ASP Isotopes Stock Up 3.5%

The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14. The firm has a market capitalization of $857.90 million, a P/E ratio of -5.95 and a beta of 3.47. The business’s fifty day moving average price is $6.51 and its two-hundred day moving average price is $8.39.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Wednesday, November 19th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.05). ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%.The firm had revenue of $4.89 million during the quarter, compared to analysts’ expectations of $2.25 million. Equities analysts expect that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Insider Buying and Selling at ASP Isotopes

In other ASP Isotopes news, Chairman Paul Elliot Mann sold 162,153 shares of the firm’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $5.75, for a total value of $932,379.75. Following the completion of the sale, the chairman owned 7,759,538 shares of the company’s stock, valued at approximately $44,617,343.50. This trade represents a 2.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Robert Ainscow sold 8,438 shares of the company’s stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $6.20, for a total transaction of $52,315.60. Following the transaction, the chief executive officer owned 1,546,255 shares in the company, valued at approximately $9,586,781. This trade represents a 0.54% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 505,591 shares of company stock worth $3,233,245. 14.40% of the stock is owned by insiders.

Institutional Investors Weigh In On ASP Isotopes

A number of large investors have recently made changes to their positions in ASPI. Quantbot Technologies LP purchased a new position in ASP Isotopes in the 3rd quarter worth $34,000. Ameritas Investment Partners Inc. raised its stake in shares of ASP Isotopes by 41.2% in the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock worth $40,000 after purchasing an additional 1,600 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of ASP Isotopes by 84.9% during the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after purchasing an additional 2,548 shares during the period. Close Asset Management Ltd purchased a new stake in ASP Isotopes in the third quarter valued at approximately $72,000. Finally, Tower Research Capital LLC TRC increased its holdings in ASP Isotopes by 96.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 10,890 shares of the company’s stock worth $80,000 after buying an additional 5,353 shares during the period. 16.80% of the stock is owned by hedge funds and other institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.